SciSparc Ltd. (NASDAQ:SPRC) Sees Large Increase in Short Interest

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 523,900 shares, a growth of 207.1% from the March 31st total of 170,600 shares. Approximately 21.4% of the company’s stock are short sold. Based on an average daily volume of 1,290,000 shares, the short-interest ratio is currently 0.4 days.

SciSparc Price Performance

Shares of SPRC opened at $1.26 on Friday. SciSparc has a one year low of $1.15 and a one year high of $23.66. The stock has a 50-day moving average price of $2.46 and a 200 day moving average price of $4.19.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and epilepsy and CannAmide, an anti-inflammatory and chronic pain solution.